Global Bifurcation Lesions Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 1925

A artery narrowing occuring adjacent to,
and/or involving, the origin of a significant side
branch.
North America dominated the bifurcation lesions market in 2016. The region is expected to maintain its dominance during the forecast period. This can be attributed to local presence of major market players, higher disposable income, and favorable reimbursement policies.
In 2018, the global Bifurcation Lesions market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Bifurcation Lesions status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bifurcation Lesions development in United States, Europe and China.

The key players covered in this study
Boston Scientific Corporation
Abbott
Cardinal Health
Medtronic
C. R. Bard, Inc.
Johnson & Johnson Services, Inc.
Spectranetics
Terumo Medical Corporation

Market segment by Type, the product can be split into
One-Stent
Two-Stent

Market segment by Application, split into
Coronary Vascular
Peripheral Vascular

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Bifurcation Lesions status, future forecast, growth opportunity, key market and key players.
To present the Bifurcation Lesions development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Bifurcation Lesions are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Bifurcation Lesions Market Size Growth Rate by Type (2014-2025)
1.4.2 One-Stent
1.4.3 Two-Stent
1.5 Market by Application
1.5.1 Global Bifurcation Lesions Market Share by Application (2014-2025)
1.5.2 Coronary Vascular
1.5.3 Peripheral Vascular
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Bifurcation Lesions Market Size
2.2 Bifurcation Lesions Growth Trends by Regions
2.2.1 Bifurcation Lesions Market Size by Regions (2014-2025)
2.2.2 Bifurcation Lesions Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Bifurcation Lesions Market Size by Manufacturers
3.1.1 Global Bifurcation Lesions Revenue by Manufacturers (2014-2019)
3.1.2 Global Bifurcation Lesions Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Bifurcation Lesions Market Concentration Ratio (CR5 and HHI)
3.2 Bifurcation Lesions Key Players Head office and Area Served
3.3 Key Players Bifurcation Lesions Product/Solution/Service
3.4 Date of Enter into Bifurcation Lesions Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Bifurcation Lesions Market Size by Type (2014-2019)
4.2 Global Bifurcation Lesions Market Size by Application (2014-2019)

5 United States
5.1 United States Bifurcation Lesions Market Size (2014-2019)
5.2 Bifurcation Lesions Key Players in United States
5.3 United States Bifurcation Lesions Market Size by Type
5.4 United States Bifurcation Lesions Market Size by Application

6 Europe
6.1 Europe Bifurcation Lesions Market Size (2014-2019)
6.2 Bifurcation Lesions Key Players in Europe
6.3 Europe Bifurcation Lesions Market Size by Type
6.4 Europe Bifurcation Lesions Market Size by Application

7 China
7.1 China Bifurcation Lesions Market Size (2014-2019)
7.2 Bifurcation Lesions Key Players in China
7.3 China Bifurcation Lesions Market Size by Type
7.4 China Bifurcation Lesions Market Size by Application

8 Japan
8.1 Japan Bifurcation Lesions Market Size (2014-2019)
8.2 Bifurcation Lesions Key Players in Japan
8.3 Japan Bifurcation Lesions Market Size by Type
8.4 Japan Bifurcation Lesions Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Bifurcation Lesions Market Size (2014-2019)
9.2 Bifurcation Lesions Key Players in Southeast Asia
9.3 Southeast Asia Bifurcation Lesions Market Size by Type
9.4 Southeast Asia Bifurcation Lesions Market Size by Application

10 India
10.1 India Bifurcation Lesions Market Size (2014-2019)
10.2 Bifurcation Lesions Key Players in India
10.3 India Bifurcation Lesions Market Size by Type
10.4 India Bifurcation Lesions Market Size by Application

11 Central & South America
11.1 Central & South America Bifurcation Lesions Market Size (2014-2019)
11.2 Bifurcation Lesions Key Players in Central & South America
11.3 Central & South America Bifurcation Lesions Market Size by Type
11.4 Central & South America Bifurcation Lesions Market Size by Application

12 International Players Profiles
12.1 Boston Scientific Corporation
12.1.1 Boston Scientific Corporation Company Details
12.1.2 Company Description and Business Overview
12.1.3 Bifurcation Lesions Introduction
12.1.4 Boston Scientific Corporation Revenue in Bifurcation Lesions Business (2014-2019)
12.1.5 Boston Scientific Corporation Recent Development
12.2 Abbott
12.2.1 Abbott Company Details
12.2.2 Company Description and Business Overview
12.2.3 Bifurcation Lesions Introduction
12.2.4 Abbott Revenue in Bifurcation Lesions Business (2014-2019)
12.2.5 Abbott Recent Development
12.3 Cardinal Health
12.3.1 Cardinal Health Company Details
12.3.2 Company Description and Business Overview
12.3.3 Bifurcation Lesions Introduction
12.3.4 Cardinal Health Revenue in Bifurcation Lesions Business (2014-2019)
12.3.5 Cardinal Health Recent Development
12.4 Medtronic
12.4.1 Medtronic Company Details
12.4.2 Company Description and Business Overview
12.4.3 Bifurcation Lesions Introduction
12.4.4 Medtronic Revenue in Bifurcation Lesions Business (2014-2019)
12.4.5 Medtronic Recent Development
12.5 C. R. Bard, Inc.
12.5.1 C. R. Bard, Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Bifurcation Lesions Introduction
12.5.4 C. R. Bard, Inc. Revenue in Bifurcation Lesions Business (2014-2019)
12.5.5 C. R. Bard, Inc. Recent Development
12.6 Johnson & Johnson Services, Inc.
12.6.1 Johnson & Johnson Services, Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Bifurcation Lesions Introduction
12.6.4 Johnson & Johnson Services, Inc. Revenue in Bifurcation Lesions Business (2014-2019)
12.6.5 Johnson & Johnson Services, Inc. Recent Development
12.7 Spectranetics
12.7.1 Spectranetics Company Details
12.7.2 Company Description and Business Overview
12.7.3 Bifurcation Lesions Introduction
12.7.4 Spectranetics Revenue in Bifurcation Lesions Business (2014-2019)
12.7.5 Spectranetics Recent Development
12.8 Terumo Medical Corporation
12.8.1 Terumo Medical Corporation Company Details
12.8.2 Company Description and Business Overview
12.8.3 Bifurcation Lesions Introduction
12.8.4 Terumo Medical Corporation Revenue in Bifurcation Lesions Business (2014-2019)
12.8.5 Terumo Medical Corporation Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details